Is it caffeine? Coffee consumption and future risk of type 2 diabetes among women with a history of gestational diabetes
Ling-Wei Chen
DOI: https://doi.org/10.1093/ajcn/nqac275
2022-11-16
Abstract:Caffeine is the most commonly used psychoactive substance in the world and has been associated with a range of health outcomes, including lower risks of Parkinson's disease and type 2 diabetes (T2D) (1). Common food sources of caffeine include coffee, tea, caffeine-containing sodas, energy drinks, and chocolate. In most regions of the world, coffee is the predominant caffeine source, but some exceptions have been noted in countries with a strong tea culture, such as the United Kingdom, Ireland, China, and Japan (2, 3). In recent years, both higher caffeine and coffee intakes have been associated with more favorable health outcomes in the general population (1, 4). Nonetheless, caution is advised for specific populations, such as pregnant women, due to its possible adverse influences on pregnancy and offspring outcomes (5). For instance, the American College of Obstetricians and Gynecologists recommends that women limit caffeine intake to <200 mg/d (approximately two 6-oz cups of coffee per day) during pregnancy, since intake at such levels has not been associated with miscarriage or preterm birth (6).
What problem does this paper attempt to address?